A Stone

Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression

Manfred P. Wirth, C. Tyrrell, Michael B. Wallace et al. · Urology · 2001 · 81 citations

Urology, Disease Progression, Genitourinary Cancer +7

Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group

A Stone, William D. Bushnell, Jon Denne et al. · European Journal of Cancer · 2011 · 57 citations

Oncology, Cancer Management, Clinical Trials +7

A phase II, double-blind, randomized multicenter study of cediranib with FOLFOX versus bevacizumab with FOLFOX in patients with previously treated metastatic colorectal cancer (mCRC): Final PFS results

David Cunningham, Rlc Wong, G D’Haens et al. · Journal of Clinical Oncology · 2008 · 29 citations

Immunology, Pathology, Oncology +16

Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.

G.A. Edelstyn, J Robertson Queen, G.D. Newsholme et al. · BMJ · 1975 · 28 citations · Full text

Lymphoid Neoplasia, Same Combination, Combination Chemotherapy +11

Exaggeration of PFS by blinded, independent, central review (BICR)

A Stone, Val Gebski, Richard Davidson et al. · Annals of Oncology · 2018 · 27 citations · Full text